GR3024550T3 - Cyclopeptides. - Google Patents
Cyclopeptides.Info
- Publication number
- GR3024550T3 GR3024550T3 GR970402189T GR970402189T GR3024550T3 GR 3024550 T3 GR3024550 T3 GR 3024550T3 GR 970402189 T GR970402189 T GR 970402189T GR 970402189 T GR970402189 T GR 970402189T GR 3024550 T3 GR3024550 T3 GR 3024550T3
- Authority
- GR
- Greece
- Prior art keywords
- asp
- arg
- ala
- gly
- denotes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4237456A DE4237456A1 (de) | 1992-11-06 | 1992-11-06 | Cyclopeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3024550T3 true GR3024550T3 (en) | 1997-12-31 |
Family
ID=6472232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR970402189T GR3024550T3 (en) | 1992-11-06 | 1997-08-27 | Cyclopeptides. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0596350B1 (el) |
| JP (1) | JP3681764B2 (el) |
| KR (1) | KR100238894B1 (el) |
| CN (1) | CN1038751C (el) |
| AT (1) | ATE154037T1 (el) |
| AU (1) | AU666586B2 (el) |
| CA (1) | CA2102447C (el) |
| CZ (1) | CZ286170B6 (el) |
| DE (2) | DE4237456A1 (el) |
| DK (1) | DK0596350T3 (el) |
| ES (1) | ES2105041T3 (el) |
| GR (1) | GR3024550T3 (el) |
| HU (1) | HU215600B (el) |
| MX (1) | MX9306885A (el) |
| NO (1) | NO309864B1 (el) |
| PL (1) | PL177772B1 (el) |
| RU (1) | RU2129563C1 (el) |
| SK (1) | SK280597B6 (el) |
| TW (1) | TW340849B (el) |
| UA (1) | UA43822C2 (el) |
| ZA (1) | ZA938281B (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019098811A2 (ko) * | 2017-11-20 | 2019-05-23 | 주식회사 노브메타파마 | Chp(시클로-히스프로)를 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816449A (en) * | 1984-08-09 | 1989-03-28 | Immunetech Pharmaceuticals | Immunotherapeutic anti-inflammatory peptide agents |
-
1992
- 1992-11-06 DE DE4237456A patent/DE4237456A1/de not_active Withdrawn
-
1993
- 1993-10-23 AT AT93117204T patent/ATE154037T1/de active
- 1993-10-23 DE DE59306654T patent/DE59306654D1/de not_active Expired - Lifetime
- 1993-10-23 ES ES93117204T patent/ES2105041T3/es not_active Expired - Lifetime
- 1993-10-23 DK DK93117204.3T patent/DK0596350T3/da active
- 1993-10-23 EP EP93117204A patent/EP0596350B1/de not_active Expired - Lifetime
- 1993-10-29 KR KR1019930022666A patent/KR100238894B1/ko not_active IP Right Cessation
- 1993-10-29 UA UA93002450A patent/UA43822C2/uk unknown
- 1993-11-01 AU AU50399/93A patent/AU666586B2/en not_active Expired
- 1993-11-02 SK SK1217-93A patent/SK280597B6/sk not_active IP Right Cessation
- 1993-11-04 PL PL93300935A patent/PL177772B1/pl unknown
- 1993-11-04 RU RU93050068A patent/RU2129563C1/ru active
- 1993-11-04 CZ CZ19932352A patent/CZ286170B6/cs not_active IP Right Cessation
- 1993-11-04 MX MX9306885A patent/MX9306885A/es unknown
- 1993-11-04 TW TW082109233A patent/TW340849B/zh active
- 1993-11-04 CA CA002102447A patent/CA2102447C/en not_active Expired - Lifetime
- 1993-11-05 CN CN93114224A patent/CN1038751C/zh not_active Expired - Lifetime
- 1993-11-05 JP JP30962593A patent/JP3681764B2/ja not_active Expired - Lifetime
- 1993-11-05 HU HU9303149A patent/HU215600B/hu unknown
- 1993-11-05 NO NO934003A patent/NO309864B1/no unknown
- 1993-11-05 ZA ZA938281A patent/ZA938281B/xx unknown
-
1997
- 1997-08-27 GR GR970402189T patent/GR3024550T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE154037T1 (de) | 1997-06-15 |
| NO309864B1 (no) | 2001-04-09 |
| CZ286170B6 (cs) | 2000-02-16 |
| CN1038751C (zh) | 1998-06-17 |
| ZA938281B (en) | 1994-06-07 |
| ES2105041T3 (es) | 1997-10-16 |
| UA43822C2 (uk) | 2002-01-15 |
| EP0596350A1 (de) | 1994-05-11 |
| PL177772B1 (pl) | 2000-01-31 |
| CZ235293A3 (en) | 1994-07-13 |
| CN1093090A (zh) | 1994-10-05 |
| DE4237456A1 (de) | 1994-05-11 |
| AU666586B2 (en) | 1996-02-15 |
| HU215600B (hu) | 1999-01-28 |
| AU5039993A (en) | 1994-05-19 |
| NO934003L (no) | 1994-05-09 |
| EP0596350B1 (de) | 1997-06-04 |
| MX9306885A (es) | 1995-01-31 |
| CA2102447C (en) | 2007-04-10 |
| HUT68321A (en) | 1995-06-28 |
| KR940011479A (ko) | 1994-06-21 |
| DE59306654D1 (de) | 1997-07-10 |
| JP3681764B2 (ja) | 2005-08-10 |
| NO934003D0 (no) | 1993-11-05 |
| CA2102447A1 (en) | 1994-05-07 |
| SK121793A3 (en) | 1995-06-07 |
| DK0596350T3 (da) | 1997-12-29 |
| RU2129563C1 (ru) | 1999-04-27 |
| SK280597B6 (sk) | 2000-04-10 |
| PL300935A1 (en) | 1994-05-16 |
| KR100238894B1 (ko) | 2000-01-15 |
| TW340849B (en) | 1998-09-21 |
| JPH0892282A (ja) | 1996-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2120303A1 (en) | Cyclic adhesion inhibitors | |
| NZ248377A (en) | Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors | |
| UA42747C2 (uk) | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту | |
| PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
| MX9703621A (es) | Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples. | |
| MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
| ES2144179T3 (es) | Inhibidores de adhesion ciclicos. | |
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
| UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
| ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
| ZA943744B (en) | Therapeutic substituted guanidines | |
| CA2148194A1 (en) | Cyclopeptides of the formula i | |
| IL104314A0 (en) | Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them | |
| ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
| GB8826428D0 (en) | Antithrombin | |
| NO941151L (no) | Lineære adhesjonsinhibitorer | |
| AU666586B2 (en) | Cyclopeptides | |
| HUP0003357A2 (hu) | Angiogén hatású ciklusos azapeptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények, eljárás ezek előállítására és alkalmazásuk | |
| DE3569541D1 (en) | Pharmacologically active peptides | |
| YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji | |
| EP0613375A4 (en) | PHARMACEUTICAL LYSINE CONTAINING POLYPEPTIDE COMPOSITIONS AND METHOD FOR USE THEREOF. | |
| EP0248231A3 (en) | Pharmacologically active peptides | |
| GR3015132T3 (en) | Novel ureas and thioureas, preparation thereof and application in therapy. | |
| NZ268039A (en) | Use of efaroxan in treating parkinson's disease |